Skip to content
Recall Observatory FDA recall evidence

Drug product

Valsartan Tablets USP 320 mg, 90 count bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., Dayton, NJ --- NDC 65862-573-90

D-1035-2019

December 31, 2018

Class II

Product summary

Firm
Aurobindo Pharma USA Inc.
Event
Event 82114
Status
Ongoing
Classification
Class II
Quantity
N/A
Official record key
drug-enforcement:D-1035-2019

Official wording

Reason: GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.

Code information: Lot Numbers: 473180004A, 473180005A, exp. date Feb 2020; 473180006A, exp. date Mar 2020; 473180016A, 473180017A, exp. date May 2020; 473170019A, exp. date Oct 2019

Distribution pattern: Product was distributed to major distribution chains throughout the United States.

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    impurity, N-nitrosodiethylamine (NDEA